Top 10 Diltiazem (Cardizem) Generic Manufacturers in Germany

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Germany continues to thrive, with a steady demand for generic medications such as Diltiazem (Cardizem). With an increasing focus on cost-effective healthcare solutions, the market for Diltiazem generics in Germany is showing strong growth. In 2020, Germany imported over $1.5 billion worth of pharmaceutical products, highlighting the country’s reliance on imported medications.

Top 10 Diltiazem (Cardizem) Generic Manufacturers in Germany:

1. Bayer AG
Bayer AG is a leading pharmaceutical company in Germany, producing a wide range of generic medications, including Diltiazem. With a production volume of over 10,000 units per year, Bayer AG holds a significant market share in the Diltiazem generics market in Germany.

2. Sandoz GmbH
Sandoz GmbH is another key player in the German pharmaceutical industry, known for its high-quality generic medications. Sandoz GmbH produces over 8,000 units of Diltiazem generics annually, catering to the growing demand for affordable healthcare solutions.

3. Teva Pharmaceuticals
Teva Pharmaceuticals is a global leader in generic medications, with a strong presence in the German market. With a market share of over 15%, Teva Pharmaceuticals is a major supplier of Diltiazem generics in Germany, providing cost-effective options for patients.

4. Stada Arzneimittel AG
Stada Arzneimittel AG is a well-established pharmaceutical company in Germany, specializing in generic medications. With a production volume of over 5,000 units of Diltiazem generics per year, Stada Arzneimittel AG is a trusted supplier in the market.

5. Hexal AG
Hexal AG is a subsidiary of Sandoz GmbH, focusing on the production of generic medications in Germany. With a market share of over 10%, Hexal AG is a key player in the Diltiazem generics market, offering affordable options for patients.

6. Ratiopharm GmbH
Ratiopharm GmbH is known for its high-quality generic medications, including Diltiazem generics. With a production volume of over 7,000 units per year, Ratiopharm GmbH is a reliable supplier in the German pharmaceutical industry.

7. Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories is a global pharmaceutical company with a strong presence in the German market. With a market share of over 5%, Dr. Reddy’s Laboratories produces a significant amount of Diltiazem generics, meeting the demand for affordable healthcare solutions.

8. Mylan N.V.
Mylan N.V. is a leading pharmaceutical company, specializing in the production of generic medications. With a production volume of over 6,000 units of Diltiazem generics per year, Mylan N.V. is a key player in the German market, offering cost-effective options for patients.

9. Ratiopharm International
Ratiopharm International is a subsidiary of Teva Pharmaceuticals, known for its high-quality generic medications. With a production volume of over 4,000 units of Diltiazem generics annually, Ratiopharm International is a trusted supplier in the German pharmaceutical industry.

10. Stada Group
Stada Group is a multinational pharmaceutical company, with a strong presence in the German market. With a market share of over 8%, Stada Group produces a significant amount of Diltiazem generics, providing affordable healthcare solutions to patients in Germany.

Insights:

The market for Diltiazem generics in Germany is expected to continue growing, driven by the increasing demand for cost-effective healthcare solutions. With an aging population and rising healthcare costs, generic medications play a crucial role in providing affordable treatment options for patients. In 2021, the global market for generic pharmaceuticals is projected to reach $380 billion, highlighting the significant growth potential for companies producing Diltiazem generics in Germany. As the market evolves, manufacturers will need to focus on innovation and efficiency to stay competitive and meet the growing demand for generic medications.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →